MPM Asset Management LLC
- SEC CIK
- 0001263048
- Latest filing
- Nov 14, 2025
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 7
- −1 vs. Q2 2023
- Portfolio value
- $186.7M
- −$17.2M (−8.4%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TRDAEntrada Therapeutics, Inc. | COM | 4,425,784 | $69.9M | 37.5% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 4,951,303 | $44.4M | 23.8% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 2,738,785 | $30.0M | 16.1% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 2,242,636 | $27.1M | 14.5% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 4,284,172 | $9.17M | 4.9% | 00.0% | Unchanged | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 6,287,101 | $4.90M | 2.6% | 00.0% | Unchanged | History |
| HARPHarpoon Therapeutics, Inc. | COM | 313,136 | $1.26M | 0.7% | 00.0% | UnchangedConverted for a 1-for-10 split | History |
Sold out since Q2 2023 (1)
Positions held at the end of Q2 2023 that are gone from this filing.